Project Grant RF1TW013269
Award Date 9/9/25
Completion Date 8/31/27
Dollars Obligated $372K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
- The federal Project Grant award in the amount of $999,940.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "DEVELOPMENT OF IMAGING OUTCOME MEASURES OF NEUROPROTECTION IN MULTIPLE SCLEROSIS USING ULTRA-HIGH GRADIENT DIFFUSION MRI". The award period is from June 1, 2024 to May 31, 2027. Through this grant, MGH...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $577,094 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Redirecting Viral Immunity to Eradicate Low Tumor Mutation Burden Lung Cancers." The award period runs from Aug 31, 2023 to Aug 29, 2025. As a leading academic medical center and research institution, MGH utilizes its...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), has been awarded a $1,000,236.00 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, effective April 1, 2024 through March 31, 2028, will fund research to "UNLOCK THE CTDNA MUTATIONAL PATTERNS FOR EARLY CANCER DETECTION AND NONINVASIVE BIOMARKERS." As a leading academic medical center and research...
- The U.S. Defense Health Agency awarded The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a $1,140,766 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The award, effective September 1, 2024 through August 31, 2027, will fund a novel mHealth balance assessment and rehabilitation project using computer vision and AI for patients with neurofibromatosis type 2 (NF2). MGH, as the primary research institution, will...
- The federal Project Grant award of $992,302 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), located in Boston, MA. This grant, awarded on September 15, 2025, supports advanced biomedical research aimed at "Targeting MHCII Ubiquitination to Induce Immune Regulation in Vascularized Composite Tissue Transplantation". MGH, a...
- The General Hospital Corporation, doing business as Massachusetts General Hospital, received a $587,117 project grant from the Defense Health Agency's Military Medical Research and Development program to develop an online platform promoting evidence-based care for patients with neurofibromatosis 1. The three-year grant, awarded June 1, 2023 and set to be completed by May 31, 2026, aims to address medical and social barriers to care through tailoring an online resource to provide specialized...
- This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $320,000.00 in funding to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on "GAMMA DELTA T CELL LIGANDS IN MS". The award period runs from November 1, 2024 to October 31, 2026. As a major recipient of federal research funding, MGH will leverage its extensive...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $1,865,846 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on July 1, 2024. The funding will support the project "TARGETING NEUROIMMUNE AND EPITHELIAL SIGNALING FOR ECZEMA TREATMENT" through June 30, 2028. MGH, a leading academic medical center and research institution, will conduct biomedical research,...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $1,485,000 Project Grant award from the Department of Health and Human Services National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310). The award period runs from September 1, 2025 to August 31, 2028. The grant supports research focused on the discovery and characterization of programmable biological systems, particularly new RNA-guided functions found in...
- The Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $1,498,368 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), with a performance period from August 1, 2024 to July 31, 2027. The grant supports research to elucidate the molecular mechanisms of tumor-immune dynamics and evolution in response to radiation, in order to optimize treatment of high-...